Search

Abstract: Introduction and aim: Chronic myeloid leukemia is a clonal myeloproliferative disorder characterized by the BCR-ABL gene rearrangement with translocation between chromosomes 9 and 22. The constitutively active BCR-ABL tyrosine kinase inhibitor became the standard frontline therapy. The molecular monitoring is essential. Method: We studied the chronic myeloid leukemia patients at the Clinical Hematology and Bone Marrow Transplant Unit Tg-Mures between 2008 and 2018. Results: We followed 59 patients, median age of 45 years, female : male ratio 1.5 : 1. 80% of the patients were in chronic phase. Sokal score was low in 61%, intermediate 27% and high in 12% of the patients. The median follow-up time was 5 years and 9 months. 59% of the patients reached molecular remission (average time 11 months). The cumulative overall survival was 80% at 5 years and 76% at 10 years. The overall survival according to disease phase was 98%, 85%, 20%; according to Sokal score it was 91%, 66%, 51%. The cumulative progression-free survival was 75% at 5 years and 50% at 10 years. Only 8% of the low risk patients are progressing opposite to 77% of the high risk patients. The cumulative probability to maintain the molecular remission for 5 years is 100%, for 10 years 91% and for 15 years 52%. Conclusion: A rising level of BCR-ABL is an early indication of the loss of response identifying the patients who need close monitoring and therapeutic change. Orv Hetil. 2019; 160(2): 67–72.

Computerized 3D echocardiography could be an alternative in order to identify viable myocardium as target area for revascularization and cell therapy after myocardial infarction, especially when other imagistic techniques (SPECT, PET) are not available. Stem cell transplantation after myocardial infarction is an innovative therapy in order to save larger myocardial areas and to recover hibernated myocardium postinfarction. We studied 39 patients with acute myocardial infarction classified in three groups, according to the treatment performed. For all patients we used computerized 3D echocardiography to determine objective parameters for complex analyze of left ventricular contractility, synchronism and remodeling. Parameters determined were: contraction dis-synchronism between different segments, time delay until reaching the maximum contraction amplitude, maximum contraction excursion, ejection fraction at different segments, ventricular volumes in different moments of cardiac cycle.